Blida: Association Launched for Biological Advancements

The establishment of the Algerian Society for Biological Advancements and Pharmaceutical Innovations marks a significant step forward for Algeria's scientific and medical community. Based in Boufarik, Blida, this new entity is poised to become a crucial hub for specialized training and cutting-edge research. Its commitment extends beyond professional development, aiming to bridge the gap in public understanding of rare diseases, which often suffer from delayed or missed diagnoses.

As highlighted by its president, Abderzak Khelfi, a respected pharmacist, toxicologist, and university professor, the society's agenda is ambitious. It prioritizes scientific vigilance in biological analyses and the promotion of innovation within the field. Notably, the integration and advancement of artificial intelligence for scientific purposes are central to their mission. This forward-thinking approach signals Algeria's intent to leverage modern technologies for medical and biological progress.

“

on compte, entre autres, actionner la veille scientifique pour tout ce qui est analyses biologiques et promouvoir les avancées dans ce domaine. L’utilisation de l’intelligence artificielle et sa promotion dans un but scientifique figure aussi dans nos priorités

The society's strategic plan includes organizing scientific meetings, congresses, and study days. These events are designed to foster collaboration, disseminate knowledge, and accelerate the adoption of new biological advancements and pharmaceutical innovations. This proactive strategy underscores a national drive to enhance the country's capabilities in these critical sectors, positioning Algeria to contribute more significantly to global scientific discourse and practice.

“

Les rencontres scientifiques, les congrès et les journées d’études sont tracés dans nos plans d’action pour mieux promouvoir les avancées biologiques et les innovations pharmaceutiques